Related Experiment Video
Updated: Mar 12, 2026
The Hypoxic Ischemic Encephalopathy Model of Perinatal Ischemia
Published on: November 19, 2008
Resveratrol post-treatment protects against neonatal brain injury after hypoxia-ischemia
Shulin Pan1, Songlin Li2, Yingying Hu1
1Department of Neonatology, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou 325000, China.
Insights
Resveratrol administered after hypoxic-ischemic injury significantly reduced brain damage in newborns. This neuroprotective effect involves inhibiting inflammation and apoptosis, suggesting a potential therapeutic strategy.
Area of Science:
- Neuroscience
- Neonatal Medicine
- Pharmacology
Background:
- Neonatal hypoxic-ischemic brain injury is a severe condition with limited therapeutic interventions.
- Resveratrol has shown promise as a preventive treatment with good tolerability and low toxicity.
Purpose of the Study:
- To investigate the neuroprotective effects of resveratrol when administered *after* neonatal hypoxic-ischemic injury.
- To explore the underlying mechanisms of resveratrol's action in this context.
Main Methods:
- Neonatal hypoxic-ischemic brain injury model in experimental subjects.
- Assessment of brain damage at 7 days post-injury.
- Analysis of inflammatory factor expression (mRNA and protein) and microglia activation.
- Evaluation of apoptosis using TUNEL staining and apoptosis-related gene expression (Bax, Bcl-2, caspase3).
Main Results:
- Post-treatment with resveratrol significantly reduced brain damage 7 days after hypoxic-ischemic injury.
- Resveratrol decreased the expression of key inflammatory factors by inhibiting microglia activation.
- Resveratrol demonstrated anti-apoptotic effects, modulating the expression of Bax, Bcl-2, and caspase3.
Conclusions:
- Resveratrol administration post-hypoxic-ischemic injury provides significant neuroprotection in a neonatal model.
- The protective mechanisms include anti-inflammatory and anti-apoptotic actions.
- Resveratrol represents a promising therapeutic strategy for neonatal hypoxic-ischemic brain injury.
Abstract:
Neonatal hypoxic-ischemic brain injury is a devastating disease with limited treatment options. Preventive treatment with resveratrol has indicated to be well tolerated and has lower toxicity in both experimental models and human patients. However, whether resveratrol administration post-hypoxic-ischemic protects against neonatal hypoxic-ischemic injury is not known. Here we reported that post-treatment with resveratrol significantly reduced brain damage at 7-day after the injury. We found that resveratrol reduced the expression levels of key inflammatory factors at the mRNA and protein levels, and at least partially via inhibiting microglia activation. Moreover, resveratrol exerted an anti-apoptotic effect, as assessed by TUNEL staining, and altered the expression of the apoptosis-related genes Bax, Bcl-2 and caspase3. Our data indicate that post-treatment with resveratrol protects against neonatal hypoxic-ischemic brain injury and suggest a promising therapeutic strategy to this disease.
